InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by Passeri Daniel R, Chairman & CEO. Officer active across 2 companies, notably Cue Biopharma, Inc.. Aggregated, 6 reports have been published. Breakdown: 3 buys · 0 sell. Total volume traded: €80k. History available since 24 September 2021. The latest transaction was filed on 16 December 2024 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Daniel R. Passeri is the Chief Executive Officer of Cue Biopharma, Inc. He leads the company, which specializes in the development of biological therapies. His leadership is essential for research and development.